Musiał-Kulik M - Search Results

1

Bioresorbable copolymer of L-lactide and ε-caprolactone for controlled paclitaxel delivery.

Musiał-Kulik M, Gębarowska K, Kasperczyk J, Pastusiak M, Janeczek H, Dobrzyński P. Musiał-Kulik M, et al. Acta Pol Pharm. 2014 Nov-Dec;71(6):1023-8. Acta Pol Pharm. 2014. PMID: 25745774 Free article.

2

The influence of paclitaxel on hydrolytic degradation in matrices obtained from aliphatic polyesters and polyester carbonates.

Musiał-Kulik M, Kasperczyk J, Jelonek K, Dobrzyński P, Gebarowska K, Janeczek H, Libera M. Musiał-Kulik M, et al. Acta Pol Pharm. 2010 Nov-Dec;67(6):664-8. Acta Pol Pharm. 2010. PMID: 21229883 Free article.

3

Double layer paclitaxel delivery systems based on bioresorbable terpolymer with shape memory properties.

Musiał-Kulik M, Kasperczyk J, Smola A, Dobrzyński P. Musiał-Kulik M, et al. Int J Pharm. 2014 Apr 25;465(1-2):291-8. doi: 10.1016/j.ijpharm.2014.01.029. Epub 2014 Feb 1. Int J Pharm. 2014. PMID: 24491529

4

Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties.

Jelonek K, Li S, Kaczmarczyk B, Marcinkowski A, Orchel A, Musiał-Kulik M, Kasperczyk J. Jelonek K, et al. Int J Pharm. 2016 Aug 20;510(1):365-74. doi: 10.1016/j.ijpharm.2016.06.051. Epub 2016 Jun 23. Int J Pharm. 2016. PMID: 27346726

5

Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells.

Zajdel A, Wilczok A, Jelonek K, Musiał-Kulik M, Foryś A, Li S, Kasperczyk J. Zajdel A, et al. Pharmaceutics. 2019 Apr 6;11(4):169. doi: 10.3390/pharmaceutics11040169. Pharmaceutics. 2019. PMID: 30959904 Free PMC article.

6

Development of antibacterial, ciprofloxacin-eluting biodegradable coatings on Ti6Al7Nb implants to prevent peri-implant infections.

Jaworska J, Jelonek K, Jaworska-Kik M, Musiał-Kulik M, Marcinkowski A, Szewczenko J, Kajzer W, Pastusiak M, Kasperczyk J. Jaworska J, et al. J Biomed Mater Res A. 2020 Apr;108(4):1006-1015. doi: 10.1002/jbm.a.36877. Epub 2020 Jan 17. J Biomed Mater Res A. 2020. PMID: 31925896

7

Bioresorbable, electrospun nonwoven for delayed and prolonged release of temozolomide and nimorazole.

Musiał-Kulik M, Włodarczyk J, Stojko M, Karpeta-Jarząbek P, Pastusiak M, Janeczek H, Kasperczyk J. Musiał-Kulik M, et al. Eur J Pharm Biopharm. 2021 Apr;161:29-36. doi: 10.1016/j.ejpb.2021.02.001. Epub 2021 Feb 7. Eur J Pharm Biopharm. 2021. PMID: 33567313

8

Cytotoxic effect of targeted biodegradable epothilone B and rapamycin co-loaded nanocarriers on breast cancer cells.

Zajdel A, Wilczok A, Jelonek K, Kaps A, Musiał-Kulik M, Kasperczyk J. Zajdel A, et al. J Biomed Mater Res A. 2021 Sep;109(9):1693-1700. doi: 10.1002/jbm.a.37164. Epub 2021 Mar 15. J Biomed Mater Res A. 2021. PMID: 33719211

9

Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.

Jurczyk M, Jelonek K, Musiał-Kulik M, Beberok A, Wrześniok D, Kasperczyk J. Jurczyk M, et al. Pharmaceutics. 2021 Mar 3;13(3):326. doi: 10.3390/pharmaceutics13030326. Pharmaceutics. 2021. PMID: 33802531 Free PMC article. Review.

10

Electrospun paclitaxel delivery system based on PGCL/PLGA in local therapy combined with brachytherapy.

Jaworska J, Smolarczyk R, Musiał-Kulik M, Cichoń T, Karpeta-Jarząbek P, Włodarczyk J, Stojko M, Janeczek H, Kordyka A, Kaczmarczyk B, Pastusiak M, Kasperczyk J. Jaworska J, et al. Among authors: musial kulik m. Int J Pharm. 2021 Jun 1;602:120596. doi: 10.1016/j.ijpharm.2021.120596. Epub 2021 Apr 20. Int J Pharm. 2021. PMID: 33857588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters